Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis

Brain Research

Volumn 1096, Issue 1, 2006, Pages 180-195

  Leichsenring, Anna ^a   Linnartz, Bettina ^a   Zhu, Xin Ran ^a   Lübbert, Hermann ^a,b   Stichel, Christine C ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Biofrontera Pharmaceuticals GmbH   (Germany)

Author keywords

Apoptosis; Degeneration; Dendritic cell; Disease progression; Inflammation; Lymphocyte

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE COURSE; FEMALE; HIPPOCAMPUS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TELENCEPHALON; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; DISEASE PROGRESSION; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NERVE DEGENERATION; SUPEROXIDE DISMUTASE; TYROSINE 3-MONOOXYGENASE;

MUS MUSCULUS;

EID: 33745242487     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.029     Document Type: Article

References (97)

1. Alexianu M.E., Kozovska M., and Appel S.H. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57 (2001) 1282-1289
2. Allan S.M., and Rothwell N.J. Inflammation in central nervous system injury. Philos. Trans. R. Soc. Lond., B Biol. Sci. 358 (2003) 1669-1677
3. Angenstein F., Niessen H.G., Goldschmidt J., Vielhaber S., Ludolph A.C., and Scheich H. Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. NeuroReport 15 (2004) 2271-2274
4. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
5. Bensley S.H. Pinacyanol erthrosinate as a stain for mast cells. Stain Technol. 27 (1952) 269-273
6. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., and Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3 (2000) 1301-1306
7. Beyer M., Wang H., Peters N., Doths S., Koerner-Rettberg C., Openshaw P.J., and Schwarze J. The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo. Respir. Res. 6 (2005) 70
8. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
9. Cha C.I., Chung Y.H., Shin C.M., Shin D.H., Kim Y.S., Gurney M.E., and Lee K.W. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res. 853 (2000) 156-161
10. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., and Gurney M.E. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6 (1995) 349-362
11. Chou S.M., and Norris F.H. Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 16 (1993) 864-869
12. Chung Y.H., Joo K.M., Kim M.J., and Cha C.I. Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation. Neurosci. Lett. 342 (2003) 151-154
13. Chung Y.H., Joo K.M., Lee Y.J., Kim M.J., and Cha C.I. Immunohistochemical study on the aggregation of ubiquitin in the central nervous system of the transgenic mice expressing a human Cu/Zn SOD mutation. Neurol. Res. 25 (2003) 395-400
14. Chung Y.H., Joo K.M., Lee Y.J., Shin D.H., and Cha C.I. Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice. Brain Res. 1003 (2004) 199-204
15. Cluskey S., and Ramsden D.B. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol. Pathol. 54 (2001) 386-392
16. Czlonkowska A., Kurkowska-Jastrzebska I., and Czlonkowski A. Role of inflammatory factors in neurodegeneration. Neurol. Neurochir. Pol. 35 Suppl. 3 (2001) 13-22
17. Dal Canto M.C., and Gurney M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145 (1994) 1271-1279
18. DePaul R., Abbs J.H., Caligiuri M., Gracco V.L., and Brooks B.R. Hypoglossal, trigeminal, and facial motoneuron involvement in amyotrophic lateral sclerosis. Neurology 38 (1988) 281-283
19. Desai J., and Swash M. Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J. Neurol. Neurosurg. Psychiatry 67 (1999) 214-216
20. Doble A., and Kennel P. Animal models of amyotrophic lateral sclerosis. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 1 (2000) 301-312
21. Eisen A., and Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 24 (2001) 564-573
22. Elliott J.L. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95 (2001) 172-178
23. Engelhardt J.I., Tajti J., and Appel S.H. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch. Neurol. 50 (1993) 30-36
24. Fischer H.G., and Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J. Immunol. 166 (2001) 2717-2726
25. Fischer H.G., Bonifas U., and Reichmann G. Phenotype and functions of brain dendritic cells emerging during chronic infection of mice with Toxoplasma gondii. J. Immunol. 164 (2000) 4826-4834
26. Gallyas F., Wolff J.R., Böttcher H., and Zaborszky L. A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Technol. 55 (1980) 299-306
27. Grant G., Hollander H., and Aldskogius H. Suppressive silver methods-a tool for identifying axotomy-induced neuron degeneration. Brain Res. Bull. 62 (2004) 261-269
28. Graves M.C., Fiala M., Dinglasan L.A., Liu N.Q., Sayre J., Chiappelli F., van Kooten C., and Vinters H.V. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 5 (2004) 213-219
29. Greter M., Heppner F.L., Lemos M.P., Odermatt B.M., Goebels N., Laufer T., Noelle R.J., and Becher B. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005) 328-334
30. Guegan C., and Przedborski S. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 111 (2003) 153-161
31. Guegan C., Vila M., Rosoklija G., Hays A.P., and Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21 (2001) 6569-6576
32. Guillemin G.J., and Brew B.J. Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J. Leukoc. Biol. 75 (2004) 388-397
33. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., and Deng H.X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
34. Haenggeli C., and Kato A.C. Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration. Neurosci. Lett. 335 (2002) 39-43
35. Hall E.D., Oostveen J.A., and Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23 (1998) 249-256
36. He B.P., and Strong M.J. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits. Neuropathol. Appl. Neurobiol. 26 (2000) 150-160
37. Henkel J.S., Engelhardt J.I., Siklos L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., and Appel S.H. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55 (2004) 221-235
38. Henkel J.S., Beers D.R., Siklos L., and Appel S.H. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol. Cell. Neurosci. 31 (2006) 427-437
39. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C., West M., and Williamson K. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82 (2002) 365-374
40. Hensley K., Fedynyshyn J., Ferrell S., Floyd R.A., Gordon B., Grammas P., Hamdheydari L., Mhatre M., Mou S., Pye Q.N., Stewart C., West M., West S., and Williamson K.S. Message and protein-level elevation of tumor necrosis factor alpha (TNF alpha) and TNF alpha-modulating cytokines in spinal cords of the G93A-SOD1 mouse model for amyotrophic lateral sclerosis. Neurobiol. Dis. 14 (2003) 74-80
41. Holasek S.S., Wengenack T.M., Kandimalla K.K., Montano C., Gregor D.M., Curran G.L., and Poduslo J.F. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 1045 (2005) 185-198
42. Huleatt J.W., and Lefrancois L. Antigen-driven induction of CD11c on intestinal intraepithelial lymphocytes and CD8+ T cells in vivo. J. Immunol. 154 (1995) 5684-5693
43. Karlsborg M., Rosenbaum S., Wiegell M., Simonsen H., Larsson H., Werdelin L., and Gredal O. Corticospinal tract degeneration and possible pathogenesis in ALS evaluated by MR diffusion tensor imaging. Amyotroph. Lateral. Scler. Other Mot. Neuron Disord. 5 (2004) 136-140
44. Kawamata T., Akiyama H., Yamada T., and McGeer P.L. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am. J. Pathol. 140 (1992) 691-707
45. Kiernan J.A., and Hudson A.J. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain 114 pt. 2 (1991) 843-853
46. Kostic V., Gurney M.E., Deng H.-X., Siddique T., Epstein C.J., and Przedborski S. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 41 (1997) 497-504
47. Kostulas N., Li H.L., Xiao B.G., Huang Y.M., Kostulas V., and Link H. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33 (2002) 1129-1134
48. Kühn K., Wellen J., Link N., Maskri L., Lübbert H., and Stichel C.C. The mouse MPTP model: gene expression changes in dopaminergic neurons. Eur. J. Neurosci. 1 (2003) 1-12
49. Lawson L.J., Perry V.H., Dri P., and Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39 (1990) 151-170
50. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., and Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288 (2000) 335-339
51. Li P.A., He Q., Cao T., Yong G., Szauter K.M., Fong K.S., Karlsson J., Keep M.F., and Csiszar K. Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 120 (2004) 115-122
52. Lin Y., Roberts T.J., Sriram V., Cho S., and Brutkiewicz R.R. Myeloid marker expression on antiviral CD8+ T cells following an acute virus infection. Eur. J. Immunol. 33 (2003) 2736-2743
53. Lloyd C.M., Richardson M.P., Brooks D.J., Al Chalabi A., and Leigh P.N. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 123 pt. 11 (2000) 2289-2296
54. Majoor-Krakauer D., Willems P.J., and Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin. Genet. 63 (2003) 83-101
55. Martin P.M., and O'Callaghan J.P. A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. J. Neurosci. Methods 58 (1995) 181-192
56. Mascalchi M., Salvi F., Valzania F., Marcacci G., Bartolozzi C., and Tassinari C.A. Corticospinal tract degeneration in motor neuron disease. AJNR Am. J. Neuroradiol. 16 (1995) 878-880
57. McGeer P.L., and McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26 (2002) 459-470
58. McMenamin P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J. Comp. Neurol. 405 (1999) 553-562
59. Metlay J.P., Witmer-Pack M.D., Agger R., Crowley M.T., Lawless D., and Steinman R.M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med. 171 (1990) 1753-1771
60. Migheli A., Atzori C., Piva R., Tortarolo M., Girelli M., Schiffer D., and Bendotti C. Lack of apoptosis in mice with ALS. Nat. Med. 5 (1999) 966-967
61. Mulder D.W., Kurland L.T., Offord K.P., and Beard C.M. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36 (1986) 511-517
62. Munoz D.G. Stains for differential diagnosis of degenerative dementias. Biotech. Histochem. 74 (1999) 311-320
63. Murayama S., Bouldin T.W., and Suzuki K. Immunocytochemical and ultrastructural studies of upper motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) 83 (1992) 518-524
64. Nelson E.L., Liang C.-L., Sinton C.M., and German D.C. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J. Comp. Neurol. 369 (1996) 361-371
65. Okamoto K., Hirai S., Shoji M., Senoh Y., and Yamazaki T. Axonal swellings in the corticospinal tracts in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) 80 (1990) 222-226
66. Okamoto K., Hirai S., Amari M., Iizuka T., Watanabe M., Murakami N., and Takatama M. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl) 85 (1993) 458-462
67. Oyanagi K., Makifuchi T., Ohtoh T., Chen K.M., Gajdusek D.C., and Chase T.N. Distinct pathological features of the gallyas- and tau-positive glia in the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. J. Neuropathol. Exp. Neurol. 56 (1997) 308-316
68. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates (2001), Academic Press, San Diego
69. Poirier J.L., Capek R., and De Koninck Y. Differential progression of Dark Neuron and Fluoro-Jade labelling in the rat hippocampus following pilocarpine-induced status epilepticus. Neuroscience 97 (2000) 59-68
70. Przedborski S. Programmed cell death in amyotrophic lateral sclerosis: a mechanism of pathogenic and therapeutic importance. Neurologist 10 (2004) 1-7
71. Reichmann G., Schroeter M., Jander S., and Fischer H.G. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J. Neuroimmunol. 129 (2002) 125-132
72. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364 (1993) 362
73. Rosler K.M., Truffert A., Hess C.W., and Magistris M.R. Quantification of upper motor neuron loss in amyotrophic lateral sclerosis. Clin. Neurophysiol. 111 (2000) 2208-2218
74. Schmued L.C., and Hopkins K.J. Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28 (2000) 91-99
75. Schmued L.C., Albertson C., and Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751 (1997) 37-46
76. Serafini B., Columba-Cabezas S., Di Rosa F., and Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157 (2000) 1991-2002
77. Shibata N. Transgenic mouse model for familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation. Neuropathology 21 (2001) 82-92
78. Stichel C.C., Singer W., and Zilles K. Ultrastructure of PkC(II/III)-immunopositive structures in rat primary visual cortex. Exp. Brain Res. 82 (1990) 575-584
79. Switzer III R.C. Application of silver degeneration stains for neurotoxicity testing. Toxicol. Pathol. 28 (2000) 70-83
80. Takahashi T., Yagishita S., Amano N., Yamaoka K., and Kamei T. Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex. Acta Neuropathol. (Berl) 94 (1997) 294-299
81. Takeuchi H., Mizuno T., Zhang G., Wang J., Kawanokuchi J., Kuno R., and Suzumura A. Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J. Biol. Chem. 280 (2005) 10444-10454
82. Tillotson M.L., and Wood J.G. Phosphotyrosine antibodies specifically label ameboid microglia in vitro and ramified microglia in vivo. Glia 2 (1989) 412-419
83. Tomik B., Adamek D., Pierzchalski P., Banares S., Duda A., Partyka D., Pawlik W., Kaluza J., Krajewski S., and Szczudlik A. Does apoptosis occur in amyotrophic lateral sclerosis? TUNEL experience from human amyotrophic lateral sclerosis (ALS) tissues. Folia Neuropathol. 43 (2005) 75-80
84. Troost D., Van den Oord J.J., and Vianney de Jong J.M. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 16 (1990) 401-410
85. Tsuchiya K., Takahashi M., Shiotsu H., Akiyama H., Haga C., Watabiki S., Taki K., Nakano I., and Ikeda K. Sporadic amyotrophic lateral sclerosis with circumscribed temporal atrophy: a report of an autopsy case without dementia and with ubiquitinated intraneuronal inclusions. Neuropathology 22 (2002) 308-316
86. Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., and Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 3155-3160
87. Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C., Shaw C.E., Brooks D.J., Leigh P.N., and Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15 (2004) 601-609
88. Ulvestad E., Williams K., Mork S., Antel J., and Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropathol. Exp. Neurol. 53 (1994) 492-501
89. Weydt P., and Moller T. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. NeuroReport 16 (2005) 527-531
90. Wolf H.K., Crain B.J., and Siddique T. Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis. Clin. Neuropathol. 10 (1991) 291-296
91. Wyss-Coray T., and Mucke L. Inflammation in neurodegenerative disease-A double-edged sword. Neuron 35 (2002) 419-432
92. Ye X., Carp R.I., Schmued L.C., and Scallet A.C. Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res. Brain Res. Protoc. 8 (2001) 104-112
93. Yin H., Lim C.C., Ma L., Gao Y., Cai Y., Li D., Liang Y., and Guo X. Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J. Neurol. 251 (2004) 1249-1254
94. Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. Neuropathology 24 (2004) 87-102
95. Zang D.W., and Cheema S.S. Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1 (G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 332 (2002) 99-102
96. Zang d.W., Yang Q., Wang H.X., Egan G., Lopes E.C., and Cheema S.S. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur. J. Neurosci. 20 (2004) 1745-1751
97. Zsombok A., Toth Z., and Gallyas F. Basophilia, acidophilia and argyrophilia of "dark" (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment. J. Neurosci. Methods 142 (2005) 145-152